FOLH1 and astrocytoma (excluding glioblastoma): The study by Nomura et al15 showed moderate PSMA expression in grade I pilocytic astrocytomas (5 patients) and high expression in grade IV glioblastomas (GBM—5 patients), while grade II diffuse (4 patients) and grade III anaplastic (5 patients) astrocytomas were negative.